Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis.
about
Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and AldosteroneA pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.Intrathecal injection of spironolactone attenuates radicular pain by inhibition of spinal microglia activation in a rat modelEffects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis inductionCoexistence of primary aldosteronism and Hashimoto's thyroiditisSpironolactone for People Age 70 Years and Older With Osteoarthritic Knee Pain: A Proof-of-Concept Trial.Effect of spironolactone on physical performance in older people with self-reported physical disability.Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people?The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritisEffects of aldosterone and related steroids on LPS-induced increased expression of inducible NOS in rat aortic smooth muscle cells.Inflammation in chronic heart failure.Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.The effect of spironolactone on experimental periodontitis in rats.Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series.Coexistence of Primary Hyperaldosteronism and Graves' Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence-A Case Report and Review of the Literature.Spironolactone-induced degradation of the TFIIH core complex XPB subunit suppresses NF-κB and AP-1 signalling.Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-κB.Saliva Interleukin-6 in patients with inflammatory bowel disease.Spironolactone (an adjuvant therapy) in rheumatoid arthritis: a case control study.Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series
P2860
Q26785911-D5A69C14-F3EA-4613-A10C-53009A331DCDQ30539790-B48A1636-194A-4EA4-9751-610D205D4C80Q34328380-0E7DC3C5-AEAC-45FB-B8A1-EECE3457D8DBQ35100840-942A4D30-1022-408F-9203-03A235998114Q36110245-F974E9CE-B591-4550-9629-619F57C80DB0Q36866515-D66FFB48-7975-485A-9A9C-A6831B34CD61Q36963464-ED2177D3-3540-4586-A0C4-679E2249AD41Q37893694-808DE880-0C94-496C-8151-69FE6543D483Q38256462-E03CE8B1-E6AD-4BE1-96BD-5DCDC1786E02Q40006665-20969427-7319-4645-A3EB-CBCB146B1385Q45165309-2B297D53-29E4-4DA9-9F4E-2773330D390FQ45928244-1CD7FBFA-E212-4524-848C-9F8B30B7C297Q46394312-EB9E0898-0B22-4564-AD2D-29AF255DDD5EQ46457429-96F9D0F9-8E71-4A6F-A80B-DB343C94FB90Q46516260-56392974-D360-43D0-A55D-D83629E693E9Q47165201-48828141-61F7-47E6-A6AB-0CD03628051CQ47647088-AA0BD89B-83F1-4ECA-8986-DB6E45BDE8D5Q54350807-DA058388-8E28-4988-8102-7650C4984BF3Q54511531-4F0CF51D-E559-4DD3-8AAF-27F18F6DE345Q55107496-BF93C458-73B5-4C5B-BA2B-9DBA2FFCB890Q56429454-EB43E7A5-AC67-4EE3-B21B-C291A96C70E9
P2860
Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Spironolactone inhibits produc ...... in the treatment of arthritis.
@en
Spironolactone inhibits produc ...... in the treatment of arthritis.
@nl
type
label
Spironolactone inhibits produc ...... in the treatment of arthritis.
@en
Spironolactone inhibits produc ...... in the treatment of arthritis.
@nl
prefLabel
Spironolactone inhibits produc ...... in the treatment of arthritis.
@en
Spironolactone inhibits produc ...... in the treatment of arthritis.
@nl
P2093
P2860
P1476
Spironolactone inhibits produc ...... in the treatment of arthritis.
@en
P2093
K Bendtzen
P R Hansen
Spironolactone/Arthritis Study Group
P2860
P304
P356
10.1046/J.1365-2249.2003.02249.X
P577
2003-10-01T00:00:00Z